Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
Sherwin-Williams
SHW
|
+$570M |
| 3 |
Amazon
AMZN
|
+$440M |
| 4 |
NXP Semiconductors
NXPI
|
+$346M |
| 5 |
International Flavors & Fragrances
IFF
|
+$334M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
+$222M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$186M |
| 3 |
Booking.com
BKNG
|
+$122M |
| 4 |
EV
Eaton Vance Corp.
EV
|
+$104M |
| 5 |
iShares MSCI Taiwan ETF
EWT
|
+$80.1M |
Sector Composition
| 1 | Technology | 23.28% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.2% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GNMK
1676
DELISTED
GenMark Diagnostics, Inc
GNMK
| $27.4M | ﹤0.01% |
1,144,775
+31,121
| +3% | +$744K |
|
1677
CBIZ
CBZ
$3.01B
| $27.3M | ﹤0.01% |
837,275
+14,555
| +2% | +$475K |
|
1678
Mativ Holdings
MATV
$674M
| $27.3M | ﹤0.01% |
556,935
+59,638
| +12% | +$2.92M |
|
1679
Veritex Holdings
VBTX
$1.88B
| $27.2M | ﹤0.01% |
831,922
+66,692
| +9% | +$2.18M |
|
1680
AstraZeneca
AZN
$247B
| $27.2M | ﹤0.01% |
547,110
-12,140
| -2% | -$604K |
|
1681
OSI Systems
OSIS
$3.95B
| $27.2M | ﹤0.01% |
282,791
+15,455
| +6% | +$1.49M |
|
1682
Northwest Natural Holdings
NWN
$1.73B
| $27.1M | ﹤0.01% |
502,485
+49,254
| +11% | +$2.66M |
|
|
MDLA
1683
DELISTED
Medallia, Inc.
MDLA
| $27M | ﹤0.01% |
968,983
+73,776
| +8% | +$2.06M |
|
1684
Celsius Holdings
CELH
$14.9B
| $27M | ﹤0.01% |
1,687,128
+178,833
| +12% | +$2.86M |
|
1685
Genworth Financial
GNW
$3.61B
| $27M | ﹤0.01% |
8,127,719
+746,951
| +10% | +$2.48M |
|
1686
Nelnet
NNI
$4.46B
| $27M | ﹤0.01% |
370,573
+27,562
| +8% | +$2M |
|
1687
Cytokinetics
CYTK
$6.12B
| $26.9M | ﹤0.01% |
1,158,128
+102,567
| +10% | +$2.39M |
|
1688
Methode Electronics
MEI
$287M
| $26.9M | ﹤0.01% |
641,105
+58,005
| +10% | +$2.43M |
|
|
ARGO
1689
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $26.9M | ﹤0.01% |
534,744
+50,292
| +10% | +$2.53M |
|
1690
Tanger
SKT
$3.86B
| $26.9M | ﹤0.01% |
1,777,126
+89,816
| +5% | +$1.36M |
|
1691
PROS Holdings
PRO
$699M
| $26.8M | ﹤0.01% |
631,707
+54,036
| +9% | +$2.3M |
|
1692
Option Care Health
OPCH
$4.62B
| $26.8M | ﹤0.01% |
1,509,232
+609,345
| +68% | +$10.8M |
|
|
CVA
1693
DELISTED
Covanta Holding Corporation
CVA
| $26.6M | ﹤0.01% |
1,921,693
+177,792
| +10% | +$2.46M |
|
|
HTO
1694
H2O America Common Stock
HTO
$1.75B
| $26.6M | ﹤0.01% |
421,755
+34,665
| +9% | +$2.18M |
|
1695
Lemonade
LMND
$3.89B
| $26.5M | ﹤0.01% |
284,967
+148,554
| +109% | +$13.8M |
|
1696
Axsome Therapeutics
AXSM
$5.91B
| $26.5M | ﹤0.01% |
468,587
+41,286
| +10% | +$2.34M |
|
1697
St. Joe Company
JOE
$3B
| $26.5M | ﹤0.01% |
618,004
+43,228
| +8% | +$1.85M |
|
|
SILK
1698
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $26.4M | ﹤0.01% |
520,514
+43,624
| +9% | +$2.21M |
|
1699
ICF International
ICFI
$1.83B
| $26.4M | ﹤0.01% |
301,616
+26,677
| +10% | +$2.33M |
|
1700
Health Catalyst
HCAT
$220M
| $26.3M | ﹤0.01% |
562,314
+32,879
| +6% | +$1.54M |
|